HEALTH

Mission Pharmacal makes Lycelle Head Lice Removal Kit available OTC

BY Michael Johnsen
SAN ANTONIO – Mission Pharmacal announced Tuesday that the former prescription Lycelle Head Lice Removal Kit will now be available without a prescription. 
 
“For those suffering with lice, being able to find a convenient, cost-effective relief and the advice from their pharmacist may mean the difference between children returning to school the next day and parents’ not missing work waiting to apply additional lice treatments,” stated Phill Dritsas SVP Mission Pharamcal Specialty Marketing. “We see pharmacists as a natural extension of our continuous commitment to helping Americans make important health decisions, whether it's choosing a hospital, doctor, diet or medication.”
 
Lycelle is a treatment for the elimination of head lice and their eggs. Lycelle uses a non-pesticidal formulation that is safe for use with children as young as two years of age and is typically effective with just one 10-minute use. 
 
Each Lycelle Head Lice Removal Kit contains one 3.38 fl. oz. bottle of pre-combing gel and a single fine-toothed comb that is used to remove the lice and their eggs. Lycelle has a pleasant wintergreen scent and a brief application time, making treating young children a less-trying experience for both child and parent. 
 
Many other head lice treatments rely on pesticides that attack the lice’s nervous system to kill the lice and, in some cases, their eggs. Recent reports have indicated that in 25 states, many forms of lice have developed resistance to over-the-counter treatments containing pesticides.
 
Mission Pharmacal will support Lycelle with an aggressive, multifaceted marketing program directed first to retail and independent pharmacies, followed by a national campaign to reach school nurses and pediatricians.
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Perrigo first-to-market with private label offering of Mucinex 1200mg DM extended-release

BY Michael Johnsen
DUBLIN – Perrigo and its partner Allergan on Tuesday announced the launch of guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets, the first OTC store brand equivalent to Mucinex 1200mg DM extended-release tablets. 
 
"This is another great example of the Perrigo and Allergan teams continuing to leverage their unique capabilities in providing U.S. consumers greater savings and access to key new store brand OTC products," stated John Hendrickson, Perrigo CEO. "These new store brand products, which are equivalent to the Mucinex brand, are an important offering to our customers as they deliver the first high-quality, value alternative available in the marketplace. Allergan has been an excellent partner in developing this range of new store brand guaifenesin ER products and we look forward to launching the remaining Mucinex equivalent products for the store brand market throughout the balance of this year."
 
Mucinex 1200mg DM extended-release tablets (guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets) are indicated to control coughs and to break up mucus, making coughs more productive. The Mucinex 1200mg DM extended-release product produced sales of approximately $108 million through food, drug and mass merchants during the last twelve months, Perrigo reported.
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Survey finds concerns over newborns keeping parents up at night

BY Michael Johnsen
PROVO, Utah – According to a new survey from Owlet Baby Care, makers of the Owlet Smart Sock, only 5% of parents of newborns to babies six months old are getting the recommended eight hours of sleep a night. As many as 43% report only getting an average of one to three hours of uninterrupted sleep per night, and 17% of moms report getting a poor night sleep every single night of the week due to their newborn. 
 
"Owlet conducted this survey to shed light on the sleep related issues that parents of newborns face, especially in the first six months," stated Kurt Workman, CEO Owlet Baby Care. "Many of us at Owlet are parents to newborns, so we understand first-hand how having a newborn can have a major impact on parents' ability to get a good night sleep. While striving for a solid eight hours when you have a newborn is pretty unrealistic, we developed our safe sleep system to provide parents with peace of mind while their baby is sleeping so they can worry a little less and get more sleep."
 
Although a majority of parents share night time responsibilities, moms are getting up far more regularly. In fact, 32% of moms report that their spouse or partner never get out of bed to check on baby at night, while only 7% of dads report that mom never got out of bed. 
 
Aside from their newborn keeping them up at night, new parents report a variety of activities and concerns preventing them from getting sleep, including concerns that their newborn is not sleeping well. For this, Owlet Baby Care features the Owlet Baby Monitor, a device that leverages pulse oximetry, the same technology used in hospitals, miniaturized into a baby sock designed to alert parents if their baby's oxygen levels and heart rate are out of range. 
 
With unintentional suffocation a leading cause of injury death among U.S. children under the age of one, moms and dads can rest easy knowing the Owlet Monitor silently watching over their little one.
 
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

H.Hutson says:
May-14-2016 10:26 am

The owlet really does help one get rest, I have used it for about a year and it was the best baby monitor investment I have ever made!!! It is my saving grace, my sleep in a little sock my baby wears, no more staying up and staring at the baby to make sure he kept breathing.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?